Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Loftis

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Frontiers in Psychiatry|November 29, 2023
Immunotherapeutic treatment of inflammation in mice exposed to methamphetamineJennifer M Loftis, Sankrith Ramani, Evan J Firsick, et al.
Psychosomatics|October 27, 2009
Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorderPeter Hauser, Benjamin J Morasco, Alex Linke, et al.
European Journal of Pharmacology|May 17, 2020
Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C-C motif) ligand 2 levels in ratsJennifer M Loftis, Tommy Navis, Jonathan Taylor, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 7, 2004
Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of careDiana L Sylvestre, Jennifer M Loftis, Peter Hauser, et al.
Psychopharmacology|November 30, 2017
Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenariansCasia Wardzala, Charles Murchison, Jennifer M Loftis, et al.
Brain, Behavior, and Immunity|June 20, 2018
Maternal prenatal depression predicts infant negative affect via maternal inflammatory cytokine levelsHanna C Gustafsson, Elinor L Sullivan, Elizabeth K Nousen, et al.
Frontiers in Neuroscience|October 22, 2019
Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative AffectHanna C Gustafsson, Kathleen F Holton, Ashley N Anderson, et al.
Journal of Psychosomatic Research|January 1, 2013
Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective studyJennifer M Loftis, Alexander L Patterson, Clare J Wilhelm, et al.
Journal of Clinical and Experimental Neuropsychology|October 6, 2021
Cognition during active methamphetamine use versus remissionMarilyn Huckans, Stephen Boyd, Grant Moncrief, et al.
Alcoholism, Clinical and Experimental Research|June 29, 2018
S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use DisorderJennifer M Loftis, Juno Valerio, Jonathan Taylor, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Frontiers in Psychiatry|November 29, 2023
Immunotherapeutic treatment of inflammation in mice exposed to methamphetamineJennifer M Loftis, Sankrith Ramani, Evan J Firsick, et al.
Psychosomatics|October 27, 2009
Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorderPeter Hauser, Benjamin J Morasco, Alex Linke, et al.
European Journal of Pharmacology|May 17, 2020
Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C-C motif) ligand 2 levels in ratsJennifer M Loftis, Tommy Navis, Jonathan Taylor, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 7, 2004
Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of careDiana L Sylvestre, Jennifer M Loftis, Peter Hauser, et al.
Psychopharmacology|November 30, 2017
Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenariansCasia Wardzala, Charles Murchison, Jennifer M Loftis, et al.
Brain, Behavior, and Immunity|June 20, 2018
Maternal prenatal depression predicts infant negative affect via maternal inflammatory cytokine levelsHanna C Gustafsson, Elinor L Sullivan, Elizabeth K Nousen, et al.
Frontiers in Neuroscience|October 22, 2019
Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative AffectHanna C Gustafsson, Kathleen F Holton, Ashley N Anderson, et al.
Journal of Psychosomatic Research|January 1, 2013
Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective studyJennifer M Loftis, Alexander L Patterson, Clare J Wilhelm, et al.
Journal of Clinical and Experimental Neuropsychology|October 6, 2021
Cognition during active methamphetamine use versus remissionMarilyn Huckans, Stephen Boyd, Grant Moncrief, et al.
Alcoholism, Clinical and Experimental Research|June 29, 2018
S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use DisorderJennifer M Loftis, Juno Valerio, Jonathan Taylor, et al.
Pageof 10